Relationship between E-cadherin, matrix metalloproteinase-7 gene expression and clinicopathological features in gastric carcinoma

Oncology Reports

Volumn 16, Issue 4, 2006, Pages 823-830

  Lee, Kyung Hee ^a   Shin, Sang Joon ^a   Kim, Kyeong Ok ^a   Kim, Min Kyoung ^a   Hyun, Myung Soo ^a   Kim, Tae Nyeun ^a   Jang, Byung Ik ^a   Kim, Sang Woon ^a   Song, Sun Kyo ^a   Kim, Hee Sun ^a   Bae, Sung Hwa ^b   Ryoo, Hun Mo ^b  

^a Yeungnam University College of Medicine   (South Korea)

^b Catholic University of Daegu   (South Korea)

Author keywords

E cadherin; MMP 7; Stomach neoplasms

Indexed keywords

CADHERIN; MATRILYSIN;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; CARCINOMA; FEMALE; GENE EXPRESSION REGULATION; HUMAN; LYMPH NODE METASTASIS; MALE; METABOLISM; MIDDLE AGED; PROGNOSIS; STOMACH TUMOR; TIME;

ADULT; AGED; CADHERINS; CARCINOMA; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; MALE; MATRIX METALLOPROTEINASE 7; MIDDLE AGED; PROGNOSIS; STOMACH NEOPLASMS; TIME FACTORS;

EID: 34547771306     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.16.4.823     Document Type: Article

References (48)

1. Fidler IJ: Molecular pathology of gastroenterological cancer. Springer-Verlag, Berlin, 1997.
2. Meyer T and Hart IR: Mechanisms of tumour metastasis. Eur J Cancer 34: 214-221, 1998. (Pubitemid 28189189)
3. Li YJ, Wei ZM, Meng YX and Ji XR: Beta-catenin up-regulates the expression of cyclinD1, c-myc and MMP-7 in human pancreatic cancer: relationships with carcinogenesis and metastasis. World J Gastroenterol 11: 2117-2123, 2005.
4. Denys H, De Wever O, Nusgens B, et al: Invasion and MMP expression profile in desmoid tumours. Br J Cancer 90: 1443-1449, 2004. (Pubitemid 38590640)
5. Egeblad M and Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2: 161-174, 2002. (Pubitemid 37328786)
6. Imai K, Yokohama Y, Nakanishi I, Ohuchi E, Fujii Y and Nakai N: Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloproteinases and enzyme properties. J Biol Chem 270: 6691-6697, 1995.
7. Parsons SL, Watson SA, Brown PD, Collins HM and Steele RJ: Matrix metalloproteinases. Br J Surg 84: 160-166, 1997. (Pubitemid 27073454)
8. Mori M, Mimori K, Shiraishi T, Tanaka S, Ueo H, Sugimachi K and Akiyoshi T: p27 expression and gastric carcinoma. Nat Med 3: 593, 1997.
9. Mori M, Mimori K, Yoshikawa Y, et al: Analysis of the gene-expression profile regarding the progression of human gastric carcinoma. Surgery 131: S39-S47, 2002. (Pubitemid 34118615)
10. Choong PF: The molecular basis of skeletal metastases. Clin Orthop Relat Res 415 (Suppl): S19-S31, 2003.
11. Guilford P: E-cadherin down-regulation in cancer: fuel on the fire? Mol Med Today 5: 172-177, 1999.
12. Siitonen SM, Kononen JT, Helin HJ, Rantala IS, Holli KA and Isola JJ: Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer. Am J Clin Pathol 105: 394-402, 1996. (Pubitemid 26105132)
13. Palacios J, Benito N, Pizarro A, Suarez A, Espada J, Cano A and Gamallo C: Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression and pathological features. Am J Pathol 146: 605-612, 1995.
14. Gupta SK, Douglas-Jones AG, Jasani B, Morgan JM, Pignatelli M and Mansel RE: E-cadherin (E-cad) expression in duct carcinoma in situ (DCIS) of the breast. Virchows Arch 430: 23-28, 1997. (Pubitemid 27073302)
15. Gamallo C, Palacios J, Suarez A, Pizarro A, Navarro P, Quintanilla M and Cano A: Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol 142: 987-993, 1993. (Pubitemid 24060574)
16. Umbas R, Schalken JA, Aalders TW, et al: Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res 52: 5104-5109, 1992.
17. Umbas R, Isaacs WB, Bringuier PP, et al: Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res 54: 3929-3933, 1994. (Pubitemid 24241218)
18. Cheng L, Nagabhushan M, Pretlow TP, Amini SB and Pretlow TG: Expression of E-cadherin in primary and metastatic prostate cancer. Am J Pathol 148: 1375-1380, 1996. (Pubitemid 26135881)
19. Matsui S, Shiozaki H, Inoue M, et al: Immunohistochemical evaluation of alpha-catenin expression in human gastric cancer. Virchows Arch 424: 375-381, 1994. (Pubitemid 24185390)
20. Syrigos KN, Krausz T, Waxman J, Pandha H, Rowlinson-Busza G, Verne J, Epenetos AA and Pignatelli M: E-cadherin expression in bladder cancer using formalin-fixed, paraffin-embedded tissues: correlation with histopathological grade, tumour stage and survival. Int J Cancer 64: 367-370, 1995. (Pubitemid 26051671)
21. Shimazui T, Schalken JA, Giroldi LA, Jansen CF, Akaza H, Koiso K, Debruyne FM and Bringuier PP: Prognostic value of cadherin-associated molecules (alpha-, beta- and gamma-catenins and p120cas) in bladder tumors. Cancer Res 56: 4154-4158, 1996. (Pubitemid 26305009)
22. Bringuier PP, Umbas R, Schaafsma HE, Karthaus HF, Debruyne FM and Schalken JA: Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors. Cancer Res 53: 3241-3245, 1993. (Pubitemid 23223289)
23. Dorudi S, Sheffield JP, Poulsom R, Northover JM and Hart IR: E-cadherin expression in colorectal cancer. An immunocytochemical and in situ hybridization study. Am J Pathol 142: 981-986, 1993. (Pubitemid 24060573)
24. Dorudi S, Hanby AM, Poulsom R, Northover J and Hart IR: Level of expression of E-cadherin mRNA in colorectal cancer correlates with clinical outcome. Br J Cancer 71: 614-616, 1995.
25. Pignatelli M, Ansari TW, Gunter P, Liu D, Hirano S, Takeichi M, Kloppel G and Lemoine NR: Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade, and advanced stage. J Pathol 174: 243-248, 1994.
26. Nakanishi Y, Ochiai A, Akimoto S, Kato H, Watanabe H, Tachimori Y, Yamamoto S and Hirohashi S: Expression of E-cadherin, alpha-catenin, beta-catenin and plakoglobin in esophageal carcinomas and its prognostic significance: immunohistochemical analysis of 96 lesions. Oncology 54: 158-165, 1997. (Pubitemid 27101765)
27. Birchmeier W and Behrens J: Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta 1198: 11-26, 1994. (Pubitemid 24159061)
28. Dai D, Chen J and Xu H: The clinical significance of E-cadherin and alpha-catenin expression in human gastric cancer. Chung-Hua chung Liu Tsa Chih 23: 35-38, 2001.
29. Joo YE, Rew JS, Kim HS, Choi SH, Park CS and Kim SJ: Changes in the E-cadherin-catenin complex expression in early and advanced gastric cancers. Digestion 64: 111-119, 2001.
30. Mei JM, Borchert GL, Donald SP and Phang JM: Matrix metalloproteinase(s) mediate(s) NO-induced dissociation of beta-catenin from membrane bound E-cadherin and formation of nuclear beta-catenin/LEF-1 complex. Carcinogenesis 23: 2119-2122, 2002. (Pubitemid 36104962)
31. Powell WC and Matrisian LM: Complex roles of matrix metalloproteinases in tumor progression. Curr Top Microbiol Immunol 213: 1-21, 1996. (Pubitemid 26165083)
32. Leeman MF, Curran S and Murray GI: New insights into the roles of matrix metalloproteinases in colorectal cancer development and progression. J Pathol 201: 528-534, 2003. (Pubitemid 38256401)
33. Huachuan Z, Xiaohan L, Jinmin S, Qian C, Yan X and Yinchang Z: Expression of matrix metalloproteinase-7 involving in growth, invasion, metastasis and angiogenesis of gastric cancer. Chin Med Sci J 18: 80-86, 2003. (Pubitemid 36723381)
34. Yamamoto H, Itoh F, Adachi Y, Fukushima H, Itoh H, Sasaki S, Hinoda Y and Imai K: Messenger RNA expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human hepatocellular carcinoma. Jpn J Clin Oncol 29: 58-62, 1996.
35. Adachi Y, Yamamoto H, Itoh F, Hinoda Y, Okada Y and Imai K: Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers. Gut 45: 252-258, 1999. (Pubitemid 29333775)
36. Ougolkov AV, Yamashita K, Mai M and Minamoto T: Oncogenic beta-catenin and MMP-7 (matrilysin) cosegregate in late-stage clinical colon cancer. Gastroenterology 122: 60-71, 2002. (Pubitemid 34049195)
37. Mori M, Barnard GF, Mimori K, Ueo H, Akiyoshi T and Sugimachi K: Overexpression of matrix metalloproteinase-7 mRNA in human colon carcinomas. Cancer 75: 1516-1519, 1995.
38. Adachi Y, Yamamoto H, Itoh F, Arimura Y, Nishi M, Endo T and Imai K: Clinicopathologic and prognostic significance of matrilysin expression at the invasive front in human colorectal cancers. Int J Cancer 95: 290-294, 2001. (Pubitemid 32847038)
39. Yamamoto H, Adachi Y, Itoh F, Iku S, Matsuno K, Kusano M, Arimura Y, Endo T, Hinoda Y, Hosokawa M and Imai K: Association of matrilysin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma. Cancer Res 59: 3313-3316, 1999. (Pubitemid 29334482)
40. Yamamoto H, Itoh F, Iku S, Adachi Y, Fukushima H, Sasaki S, Mukaiya M, Hirata K and Imai K: Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: clinicopathologic and prognostic significance of matrilysin expression. J Clin Oncol 19: 1118-1127, 2001. (Pubitemid 32176289)
41. Yamashita K, Mori M, Shiraishi T, Shibuta K and Sugimachi K: Clinical significance of matrix metalloproteinase-7 expression in esophageal carcinoma. Clin Cancer Res 6: 1169-1174, 2000. (Pubitemid 30159381)
42. Liu XP, Kawauchi S, Oga A, Tsushimi K, Tsushimi M, Furuya T and Sasaki K: Prognostic significance of matrix metalloproteinase-7 (MMP-7) expression at the invasive front in gastric carcinoma. Jpn J Cancer Res 93: 291-295, 2002. (Pubitemid 34464365)
43. Adachi Y, Itoh F, Yamamoto H, Matsuno K, Arimura Y, Kusano M, Endoh T, Hinoda Y, Oohara M, Hosokawa M and Imai K: Matrix metalloproteinase matrilysin (MMP-7) participates in the progression of human gastric and esophageal cancers. Int J Oncol 13: 1031-1035, 1998. (Pubitemid 28506074)
44. Honda M, Mori M, Ueo H, Sugimachi K and Akiyoshi T: Matrix metalloproteinase-7 expression in gastric carcinoma. Gut 39: 444-448, 1996. (Pubitemid 26338536)
45. Nagashima Y, Hasegawa S, Koshikawa N, Taki A, Ichikawa Y, Kitamura H, Misugi K, Kihira Y, Matuo Y, Yasumitsu H and Miyazaki K: Expression of matrilysin in vascular endothelial cells adjacent to matrilysin-producing tumors. Int J Cancer 72: 441-445, 1997. (Pubitemid 27325871)
46. Senota A, Itoh F, Yamamoto H, Adachi Y, Hinoda Y and Imai K: Relation of matrilysin messenger RNA expression with invasive activity in human gastric cancer. Clin Exp Metastasis 16: 313-321, 1998. (Pubitemid 28255526)
47. Yonemura Y, Endou Y, Fujita H, Fushida S, Bandou E, Taniguchi K, Miwa K, Sugiyama K and Sasaki T: Role of MMP-7 in the formation of peritoneal dissemination in gastric cancer. Gastric Cancer 3: 63-70, 2000. (Pubitemid 32182878)
48. Yonemura Y, Fujimura T, Ninomiya I, Kim BS, Bandou E, Sawa T, Kinoshita K, Endo Y, Sugiyama K and Sasaki T: Prediction of peritoneal micrometastasis by peritoneal lavaged cytology and reverse transcriptase-polymerase chain reaction for matrix metalloproteinase-7 mRNA. Clin Cancer Res 7: 1647-1653, 2001. (Pubitemid 32708631)